IEN1601-Tetrahydrouridine
Tetrahydrouridine,≥85%
【英文同义名】:3, 4, 5, 6-Tetrahydrouridine, THU, H4Urd, NSC-112907
【中文同义名】:四氢尿苷
订购信息:(原装进口,常备现货)
| 品 牌 | 产品名称 | 产品货号 | 规 格 | 目录价(元) |
| Gene Operation | Tetrahydrouridine | IEN1601-0010MG | 10 mg | ¥1,629.00 |
产品描述
嘧***核苷类似物四氢尿苷(Tetrahydrouridine, THU)是一种有效的胞苷脱氨酶(CDA)抑制剂,Ki值为2.4×10-7 M。竞争性阻断酶活性位点,比作用于内源性胞嘧***的活性更强 [1]。THU是一种强力的多药耐药性调节剂和***线增敏剂。体内外研究中,常与胞苷类似物,如5-氮杂胞苷[2],阿糖胞苷(Ara-C) [3],吉西他滨 (dFdC)[4],和地西他滨[5]联合使用,因为四氢尿苷能够维持这些药物的半衰期,从而临床前和临床实验中增强以上药物的抗肿瘤特性。
靶点
| 靶点 | CDA |
| IC50(半数有效浓度) | 2.4×10-7 M (Ki) [1] |
化学特性
| Cas No.: 18771-50-1 | 分子量: 248.2 |
| 分子式: C9H16N2O6 | 纯度: ≥85% |
| 同义名: 3, 4, 5, 6-Tetrahydrouridine, THU, H4Urd, NSC-112907 |
| 化学名: 1-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one |
| 外观: White to off-white solid |
| 溶解: 溶于Water (up to 100 mM) |
| 保存::3年 -20℃粉状 |
储存液配制
| 储存液 (1 ml H2O体系) | 1 mM | 5 mM | 10 mM | 25 mM | 50 mM | 100 mM |
| 质量(mg) | 0.2482 | 1.2410 | 2.4820 | 6.2050 | 12.4100 | 24.8200 |
结构式

使用浓度(仅作参考)
Tetrahydrouridine的具体使用浓度请参考相关文献,并根据自身实验条件(如实验目的,细胞种类,培养特性等)进行摸索和优化。
参考文献
[1] Cohen RM, et al. Cytidine deaminase from Escherichia coli: purification, properties and
inhibition by the potential transition state analog 3,4,5,6-tetrahydrouridine. J Biol Chem. 246(24): 7561–5 (1971).
[2] Neil GL, et al. Enhancement by tetrahydrouridine (NSC-112907) of the oral activity of 5-azacytidine (NSC-102816) in L1210 leukemic mice. Cancer Chemother Rep. 59(3):459–65 (1975).
[3] Riccardi R, et al. Influence of tetrahydrouridine on the pharmacokinetics of intrathecally administered 1-beta-D-arabinofuranosylcytosine. Cancer Res. 42(5):1736-9 (1982).
[4] Beumer JH, et al. Modulation of gemcitabine (2,2-difluoro-2-deoxycytidine) pharmacokinetics, metabolism, and bioavailability in mice by 3,4,5,6-tetrahydrouridine. Clin Cancer Res. 14(11):3529-35 (2008).
[5] Lavelle D, et al. Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabine. Blood. 119(5):1240-7 (2012).